Detailed Information on Publication Record
2022
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
ARKADIUSZ, Dziedzic, Julien ISSA, Mohammad Salman HUSSAIN, Tanasiewicz MARTA, Wojtyczka ROBERT et. al.Basic information
Original name
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
Authors
ARKADIUSZ, Dziedzic, Julien ISSA, Mohammad Salman HUSSAIN (356 India, belonging to the institution), Tanasiewicz MARTA, Wojtyczka ROBERT, Kubina ROBERT, Konwinska Marta DYSZKIEWICZ and Abanoub RIAD (818 Egypt, guarantor, belonging to the institution)
Edition
Frontiers in Public Health, LAUSANNE, FRONTIERS MEDIA SA, 2022, 2296-2565
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30304 Public and environmental health
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.200
RIV identification code
RIV/00216224:14110/22:00126335
Organization unit
Faculty of Medicine
UT WoS
000891406400001
Keywords in English
cross-sectional studies; COVID-19 vaccines; decision making; healthcare professionals; vaccination hesitancy; Poland
Tags
International impact, Reviewed
Změněno: 5/4/2023 08:17, Mgr. Tereza Miškechová
Abstract
V originále
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
Links
EF18_053/0016952, research and development project |
| ||
EF19_073/0016943, research and development project |
| ||
MUNI/A/1402/2021, interní kód MU |
| ||
MUNI/IGA/1104/2021, interní kód MU |
|